PointState Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-21,000
| Closed | -$5.04M | – | 69 |
|
|
2021
Q4 | $5.04M | Sell |
21,000
-44,500
| -68% | -$10.7M | 0.08% | 63 |
|
|
2021
Q3 | $18.5M | Buy |
65,500
+24,900
| +61% | +$7.05M | 0.31% | 42 |
|
|
2021
Q2 | $14.1M | Sell |
40,600
-6,800
| -14% | -$2.35M | 0.24% | 51 |
|
|
2021
Q1 | $13.3M | Buy |
47,400
+38,900
| +458% | +$10.9M | 0.26% | 56 |
|
|
2020
Q4 | $2.08M | Buy |
+8,500
| New | +$2.08M | 0.04% | 92 |
|
|
2020
Q3 | – | Sell |
-56,995
| Closed | -$15.2M | – | 95 |
|
|
2020
Q2 | $15.2M | Buy |
+56,995
| New | +$15.2M | 0.46% | 37 |
|
|
2020
Q1 | – | Sell |
-98,887
| Closed | -$29.3M | – | 61 |
|
|
2019
Q4 | $29.3M | Buy |
+98,887
| New | +$29.3M | 0.53% | 36 |
|
|
2019
Q2 | – | Sell |
-4,500
| Closed | -$1.06M | – | 94 |
|
|
2019
Q1 | $1.06M | Buy |
+4,500
| New | +$1.06M | 0.02% | 94 |
|
|
2018
Q3 | – | Sell |
-86,900
| Closed | -$25.2M | – | 126 |
|
|
2018
Q2 | $25.2M | Sell |
86,900
-60,405
| -41% | -$17.5M | 0.29% | 61 |
|
|
2018
Q1 | $40.3M | Sell |
147,305
-620,912
| -81% | -$170M | 0.44% | 58 |
|
|
2017
Q4 | $245M | Buy |
768,217
+493,787
| +180% | +$157M | 2.38% | 10 |
|
|
2017
Q3 | $85.9M | Buy |
274,430
+118,500
| +76% | +$37.1M | 0.73% | 32 |
|
|
2017
Q2 | $42.3M | Sell |
155,930
-177,570
| -53% | -$48.2M | 0.46% | 47 |
|
|
2017
Q1 | $91.2M | Buy |
+333,500
| New | +$91.2M | 0.95% | 29 |
|
|
2016
Q4 | – | Sell |
-210,000
| Closed | -$65.7M | – | 116 |
|
|
2016
Q3 | $65.7M | Buy |
+210,000
| New | +$65.7M | 0.68% | 35 |
|
|
2015
Q3 | – | Sell |
-139,200
| Closed | -$56.2M | – | 87 |
|
|
2015
Q2 | $56.2M | Sell |
139,200
-318,800
| -70% | -$129M | 0.66% | 34 |
|
|
2015
Q1 | $193M | Buy |
458,000
+333,000
| +266% | +$141M | 2.62% | 8 |
|
|
2014
Q4 | $42.4M | Buy |
+125,000
| New | +$42.4M | 0.72% | 42 |
|